Skip to content

Eburnamonine

Drug profile

Also known as: (+)-cis-Eburnamonine, (+)-Eburnamonine, (+)-Vincamone, cervoxan, d-Eburnamonine, eburnamonine monohydrochloride, eburnamonine phosphate

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Eburnamonine is a drug catalogued in DrugCentral. DrugCentral lists 4 molecular targets, including CHRM3, CHRM1 and CHRM4.

  • Molecular targets: CHRM3, CHRM1, CHRM4 and CHRM2 (4 listed in DrugCentral).
  • Molecular formula: C19H22N2O; molecular weight 294.40 g/mol.

Mechanism & targets

Molecular targets (4)

TargetGeneActionActivity
Muscarinic acetylcholine receptor M3CHRM3allosteric modulatorKd 5.20
Muscarinic acetylcholine receptor M1CHRM1allosteric modulatorKd 5.10
Muscarinic acetylcholine receptor M4CHRM4allosteric modulatorKd 4.60
Muscarinic acetylcholine receptor M2CHRM2allosteric modulatorKd 4.20

Chemical structure

Molecular formulaC19H22N2O
Molecular weight294.40 g/mol
CAS number474-00-0
InChIKeyWYJAPUKIYAZSEM-RBUKOAKNSA-N
PubChem CID92112
CC[C@]12CCCN3CCC4=C([C@@H]13)N(C1=CC=CC=C41)C(=O)C2

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Eburnamonine work?

Its molecular targets in DrugCentral include CHRM3 (allosteric modulator), CHRM1 (allosteric modulator), CHRM4 (allosteric modulator) and CHRM2 (allosteric modulator).

What is the chemical formula of Eburnamonine?

Eburnamonine has the molecular formula C19H22N2O and a molecular weight of 294.40 g/mol.

Browse: all drugs starting with E · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets4
Indications0
FormulaC19H22N2O
DrugCentral ID3170
Interactive profile